Williams K L. Endotoxins: Pyrogens, LAL testing and depyrogenation(2nd ed.)[M]. N.Y. USA: Marcel Dekker Inc, 2001:256-263
[2]
Neidhardt F C, Ingraham J L, Schaechter M. Physiology of the bacterial cell: A molecular approach[M]. Sunderland, MA: Sinauer Associates, 1990
[3]
Elin R J, Wolff S M, McAdam K P W J, et al. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans[J]. Journal of Infectious Diseases, 1981, 144 (4):329-336
FDA. US Department of health and human services. Guideline on validation of the Limulus amebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices[M]. Rockville, MD, 1987:20857
[6]
USP. United states pharmacopeia 30th revision and national formulary[M]. Rochville, MD: The United States Pharmacopeial Convention, 2007:109-113
[7]
Petsch D, Anspach F B. Endotoxin removal from protein solutions[J]. Journal of Biotechnology, 2000, 76 (2):97-119
[8]
Zhang C, Liu W, Sun W, et al. Endotoxin contamination and control in surface water sources and a drinking water treatment plant in Beijing, China[J]. Water Research, 2013, 47 (11):3591-3599
Ohkouchi Y, Ishikawa S, Takahashi K, et al. Factors associated with endotoxin fluctuation in aquatic environment and characterization of endotoxin removal in water treatment process[J]. Environmental Engineering Research, 2007, 44:247-254
[11]
Rapala J, Lahti K, R？s？nen L A, et al. Endotoxins associated with cyanobacteria and their removal during drinking water treatment[J]. Water Research, 2002, 36 (10):2627-2635
[12]
Annadotter H, Cronberg G, Nystrand R, et al. Endotoxins from cyanobacteria and gram-negative bacteria as the cause of an acute influenza-like reaction after inhalation of aerosols[J]. EcoHealth, 2005, 2 (3):209-221
[13]
Gehr R, Uribe S P, Baptista I F D S, et al. Concentrations of endotoxins in waters around the island of Montreal, and treatment options[J]. Water Quality Research Journal of Canada, 2008, 43(4):291-303
Korsholm E, S？gaard H. An evaluation of direct microscopical counts and endotoxin measurements as alternatives for total plate counts[J]. Water Research,1988, 22:783-788
[17]
Goyal S M, Gerba C P, Occurrence of endotoxins in groundwater during the land application of wastewater[J]. Journal of Environmental Science & Health Part A, 1982,17:187-196
[18]
O'Toole J, Sinclair M, Jeavons T, et al. Alternative water sources and endotoxin[J]. Water Science & Technology, 2008, 58 (3):603-607
[19]
Abdulraheem A, Mustafa S, Al-Saffar N, et al. Detection of bacterial endotoxin in drinking tap and bottled water in Kuwait[J]. Environmental Monitoring and Assessment, 2012, 184 (12):7323-7328
[20]
Anderson W B, Mayfield C I, Dixon D G. et al.Endotoxin inactivation by selected drinking water treatment oxidants[J]. Water Research,2003, 37(19): 4553-4560
[21]
Reyes M I, Pérez C M, Negrón E L. Microbiological assessment of house and imported bottled water by comparison of bacterial endotoxin concentration, heterotrophic plate count and fecal coliform count[J]. Puerto Rico Health Sciences, 2008, 27(1):21-26
[22]
Klein E, Pass T, Harding G B, et al. Microbial and endotoxin contamination in water and dialysate in the central United States[J]. Artificial Organs, 1990, 14 (2):85-94
[23]
Laurence R A, Lapierre S T. Quality of hemodialysis water: A 7-year multicenter study[J]. American Journal of Kidney Diseases, 1995, 25 (5):738-750
[24]
Bambauer R, Schauer M, Jung W K, et al. Contamination of dialysis water and dialysate. A survey of 30 centers[J]. ASAIO Journal, 1994, 40 (4):1012-1016
[25]
Arvanitidou M, Spaia S, Askepidis N, et al. Endotoxin concentration in treated water of all hemodialysis units in Greece and inquisition of influencing factors[J]. Journal of Nephrology, 1999, 12 (1):32-37
ISO 26722—2009. Water treatment equipment for haemodialysis applications and related therapies [S].
[29]
European Pharmacopoeia Commission. European Pharmacopoeia, 5th (ed.) Monograph 2005: 1167, Haemodialysis Solution[S]. Concentrated,Water for Diluting
[30]
Kawanishi H, Akiba T, Masakane I, et al. Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008[J]. Therapeutic Apheresis and Dialysis, 2009, 13 (2):161-166
[31]
Rylander R. The role of endotoxin for reactions after exposure to cotton dust[J]. American Journal of Industrial Medicine, 1987, 12 (6):687-697
[32]
Anderson W B, Slawson R M, Mayfield C I. A review of drinking-water-associated endotoxin, including potential routes of human exposure[J]. Canadian Journal of Microbiology, 2002, 48 (7):567-587
[33]
Smit LAM, Spaan S, Heederik D. Endotoxin exposure and symptoms in wastewater treatment workers[J]. American Journal of Industrial Medicine, 2005, 48(1): 30-39
[34]
Hwang S H, Park D U, Joo S I, et al. Comparison of endotoxin levels and Gram-negative bacteria under different conditions in microbial laboratories and a biowaste site[J]. chemosphere, 2011,85: 135-139
[35]
Aro S, Muittari A, Virtanen P. Bathing fever epidemic of unknown aetiology in Finland[J]. International Journal of Epidemiology, 1980, 9 (3):215-218
[36]
McGregor F R, Walenczak W D, Rogers R. Case study: Ozone-based water treatment for high quality air and water in a municipal swimming center . San Francisco, Calif: In Ozone in Water and Wastewater Treatment: Proceedings of the International Ozone Association's 11th Ozone World Congress, 1993. S-12A-1-S-12A-8
[37]
Best J H, Pflugmacher S, Wiegand C, et al. Effects of enteric bacterial and cyanobacterial lipopolysaccharides, and of microcystin-LR, on glutathione S-transferase activities in zebra fish (Danio rerio)[J]. Aquat Toxicol, 2002, 60 (3/4):223-231
[38]
Diluzio N R, Friedmann T J. Letter: Bacterial endotoxins in the environment[J]. Nature, 1973, 244 (5410):49-51
[39]
Snella M C, Rylander R. Endotoxins: A neglected environmental factor[J]. Sozial-und Praventivmedizin, 1977, 22 (3):137-138
[40]
Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice[J]. ISME J, 2013, 7:880-884.
[41]
Creely S J, McTernan P G, Kusminski C M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes[J]. American Journal of Physiology-Endocrinology and Metabolism, 2007, 292 (3):E740-E747
